Nonalcoholic fatty liver and left ventricular remodelling: now the prospective evidence

Leonardo A Sechi^{1

2}, Giorgio Soardo^{1

3}, Cristiana Catena^{1

2}

Affiliations

¹ Internal Medicine.
² European Hypertension Excellence Center.
³ Liver Unit, Department of Medicine, University of Udine School of Medicine, Udine, Italy.

Editorial

Leonardo A Sechi et al. J Hypertens. 2021.

. 2021 May 1;39(5):864-866.

doi: 10.1097/HJH.0000000000002750.

Leonardo A Sechi^{1

2}, Giorgio Soardo^{1

3}, Cristiana Catena^{1

2}

¹ Internal Medicine.
² European Hypertension Excellence Center.
³ Liver Unit, Department of Medicine, University of Udine School of Medicine, Udine, Italy.

No abstract available

Comment on

Fatty liver index and left ventricular mass: prospective associations from two independent cohorts.
Li X, Heiskanen JS, Ma H, Heianza Y, Guo Y, Kelly TN, He H, Fonseca VA, Chen W, Harville EW, Ruohonen S, Hutri-Kähönen N, Bazzano LA, Raitakari OT, Qi L. Li X, et al. J Hypertens. 2021 May 1;39(5):961-969. doi: 10.1097/HJH.0000000000002716. J Hypertens. 2021. PMID: 33560053

1. Younossi Z, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease. Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 67:73–84.
1. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018; 67:328–357.
1. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21:3–16.
1. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in nonalcoholic fatty liver disease. J Hepatol 2008; 49:608–612.
1. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005; 42:987–1000.